Article

Let's talk about sex

Author(s):

Jon Garinn blog image

Sex is one topic that always seems to generate interest, even at a cancer research conference. Among the many studies presented at this year's annual meeting of the American Society of Clinical Oncology: a first-of-its-kind examination of spouses or long-term partners of patients with HPV-positive oropharyngeal cancers, which are located at the tongue, tonsils, pharynx and soft palate. Gypsyamber D'Souza, an associate professor of epidemiology at Johns Hopkins University in Baltimore and the study's lead author, says fear of transmitting the virus can cause couples anxiety, resulting in reduced sexual intimacy and even divorce. She and her colleagues set out to learn whether sexual partners were at increased risk of infection from the human papilloma virus and if they needed to change their sexual behaviors.The study found that the spouses or partners of patients with HPV-positive oral cancers were no more at risk of developing the disease than the general population.Taking oral rinse samples from 166 participants with HPV-positive oral cancer and 94 of their spouses or partners, the researchers tested the samples for HPV DNA. After one year, samples were again taken and tested. The prevalence of HPV infection among partners (6.5 percent) was comparable to the general population. Nearly all sexually active people will be infected with at least one type of HPV in their lifetime, even if they have only one sexual partner. The majority of infections do not develop into cancer, and most people exposed to the virus manage to "clear it," according to D'Souza.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content